The benefits of long-chain omega-3 fatty acids may also include improved immune B cell function, according to a study. “This study tested the hypothesis that DHA from fish oil is incorporated into the B cell membrane to alter lipid microdomain clustering and enhance B cell function," the researchers said.
A third of fish samples collected from 674 retail establishments in 21 states were determined to be mislabeled relative to U.S. Food and Drug Administration guidelines, Oceana reports. "With lagging federal oversight and minimal government inspection despite rising fish imports, and without sampling along the supply chain, it is difficult to determine if fraud is occurring at the boat, during processing, at the wholesale level, at the retail counter or somewhere else along the way," according to the organization.
The North American Olive Oil Association filed suit Feb. 6 against The Gourmet Factory, charging it with "deceptive misbranding" of its Capatriti brand of 100% olive oil, which the NAOOA says is low-grade pomace oil. The suit is the first time the NAOOA has sued an olive oil manufacturer.
Long-term intake of omega-3 fatty acids has been conclusively linked to a reduced risk of cancer, according to scientists from the University of Guelph in Ontario. "The fact that a food nutrient can have a significant effect on tumour development and growth is remarkable and has considerable implications in breast cancer prevention," said researcher David Ma.
Life sciences company Royal DSM hopes to make a splash in generic pharmaceuticals with its purchase of Ocean Nutrition Canada, a leader in fish-oil-derived omega-3 fatty acids for dietary supplements. DSM says the generic-drug market for omega-3s is largely unexplored ahead of this year's patent expiration for GlaxoSmithKline's lipid regulator Lovaza.